Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow INTEGRA LIFESCIENCES HOLDINGS CORP

Get SEC filing alerts via email and in your feed for INTEGRA LIFESCIENCES HOLDINGS CORP

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

About INTEGRA LIFESCIENCES HOLDINGS CORP

Integra LifeSciences is a global medical technology company specializing in surgical, neurosurgical, ENT, and regenerative care products. It offers advanced devices and regenerative solutions for brain, spine, wound, and reconstructive procedures. Serving hospitals, clinics, and surgeons worldwide, the company emphasizes innovation, quality, and expanding care pathways, with a focus on improving patient outcomes through leading-edge technologies and strategic acquisitions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from INTEGRA LIFESCIENCES HOLDINGS CORP

1
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports $391.9 Million Revenue and Operating Income Turnaround in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports $516.5 Million Net Loss Amid Goodwill Impairment and Revenue Growth

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports 5.6% Revenue Growth in Q3 2025 Despite Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports $484.1 Million Net Loss Due to Goodwill Impairment

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports $25.3 Million Net Loss and $382.7 Million Revenue in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
INTEGRA LIFESCIENCES HOLDINGS CORP Integra LifeSciences Reports Mixed Q3 2024 Results, Revenue Growth Offset by Operational Challenges and Recall

Via official filing (AI summary) | over 1 year ago | 0 comments